sign in
join free
verified
Copper
Genetron Health
verified
Genetron Health
Beijing,China
Genetron Health
Beijing,China
verified
Copper Member
Genetron Health
favorite supplier
verified
Copper Member
Genetron Health
Beijing,China
Scan QR code
Access to mobile station
Genetron Health
Genetron Health is a leading precision oncology platform company in China that specializes in the research and application of cancer molecular profiling. We provide early cancer screening, diagnosis and treatment recommendations, continuous disease monitoring and care, and biopharma development services that cover the entire spectrum of cancer management. The Company is committed to applying innovative genomics technology to cancer-related diagnosis and treatment and to ultimately defeating cancer.
In the field of early cancer screening, Genetron Health’s proprietary liquid biopsy assay, HCCscreen, for hepatocellular carcinoma has received "Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA), and was cited by multiple expert consensus and guidelines, including the first patient-oriented liver cancer prevention and treatment guidelines in China. At the same time, the Company has started to enroll subjects for the clinical trial of NGS-based HCCscreen. The PCR-based HCCscan has also started clinical trials for registration requirements.
In the field of diagnosis and monitoring, leveraging Genetron Health’s patented technologies such as One-Step Seq Method, the Company has developed a comprehensive IVD product portfolio across NGS, dPCR and qPCR, including 8 instruments and assays have been approved by National Medical Products Administration (NMPA) and local medical products administrations for clinical use in China, and 10 products obtained CE-marks. The Company provides comprehensive diagnostic services and products that cover solid tumors and hematological tumors, and has collaborated with the top hospitals and research institutions in China.
In the field of biopharma development services, the Company provides professional, one-stop solutions in genomics research and clinical development, covering biomarker evaluation for molecularly targeted therapy and immuno-therapy, clinical trial enrollment, companion diagnostics development and CDx registration application, and others. Genetron Health has reached strategic cooperation agreements with dozens of top biopharmaceutical companies and contract research organizations (CROs) both at home and abroad.
+
More
In the field of early cancer screening, Genetron Health’s proprietary liquid biopsy assay, HCCscreen, for hepatocellular carcinoma has received "Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA), and was cited by multiple expert consensus and guidelines, including the first patient-oriented liver cancer prevention and treatment guidelines in China. At the same time, the Company has started to enroll subjects for the clinical trial of NGS-based HCCscreen. The PCR-based HCCscan has also started clinical trials for registration requirements.
In the field of diagnosis and monitoring, leveraging Genetron Health’s patented technologies such as One-Step Seq Method, the Company has developed a comprehensive IVD product portfolio across NGS, dPCR and qPCR, including 8 instruments and assays have been approved by National Medical Products Administration (NMPA) and local medical products administrations for clinical use in China, and 10 products obtained CE-marks. The Company provides comprehensive diagnostic services and products that cover solid tumors and hematological tumors, and has collaborated with the top hospitals and research institutions in China.
In the field of biopharma development services, the Company provides professional, one-stop solutions in genomics research and clinical development, covering biomarker evaluation for molecularly targeted therapy and immuno-therapy, clinical trial enrollment, companion diagnostics development and CDx registration application, and others. Genetron Health has reached strategic cooperation agreements with dozens of top biopharmaceutical companies and contract research organizations (CROs) both at home and abroad.
leave a message
-
phone :
view details
-
address :
1-2/F, Building 11, Zone 1, 8 Life Science Parkway, Zhongguancun Life Science Park, Changping District, Beijing
-
postcode :
102206
-
website :
https://www.genetronhealth.com/en/